Kennedy Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.73M | Sell |
|
|||||
|
2022
Q3 | $1.84M | Sell |
|
|||||
|
2022
Q2 | $2.39M | Sell |
|
|||||
|
2022
Q1 | $2.61M | Buy |
|
|||||
|
2021
Q4 | $2.1M | Buy |
|
|||||
|
2021
Q3 | $7.08M | Sell |
|
|||||
|
2021
Q2 | $10.1M | Sell |
|
|||||
|
2021
Q1 | $7.44M | Buy |
|
|||||
|
2020
Q4 | $8.9M | Sell |
|
|||||
|
2020
Q3 | $7.09M | Sell |
|
|||||
|
2020
Q2 | $11.5M | Sell |
|
|||||
|
2020
Q1 | $10.8M | Sell |
|
|||||
|
2019
Q4 | $15.5M | Sell |
|
|||||
|
2019
Q3 | $13.3M | Sell |
|
|||||
|
2019
Q2 | $18M | Sell |
|
|||||
|
2019
Q1 | $16.7M | Sell |
|
|||||
|
2018
Q4 | $12M | Sell |
|
|||||
|
2018
Q3 | $22.5M | Sell |
|
|||||
|
2018
Q2 | $11.3M | Buy |
|
|||||
|
2018
Q1 | $4.89M | Sell |
|
|||||
|
2017
Q4 | $7.08M | Buy |
|
|||||
|
2017
Q3 | $6.35M | Buy |
|